An interventional study of Pedometer and MRI in Whiplash Associated Disorders (WAD) and Whiplash, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Northwestern University · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is investigating whether changes in the shape and size of bodily muscles and spinal cord anatomy can influence recovery rates following a motor vehicle collision (MVC). The objective is to demonstrate that the presence of muscle and spinal cord degeneration and associated muscle weakness is the consequence of a mild MVC-related injury involving the cervical spinal cord.
Whiplash is a condition that consists of patients that display varying degrees of pain and disability. Most patients should expect full-recovery within the first 2-3 months post injury. At the other end of the spectrum is a group of patients (\~ 25%) who continue to have moderate-severe pain-related disability in the long-term. Reasons for this transition to chronicity are largely unknown. The situation would benefit if there were radiological findings of the disorder. However, clear and consistent findings of injured tissues on standard radiological exams remain elusive.
As part of this study, the investigators will innovatively investigate measures to 1) quantify the temporal development of widespread muscle degeneration, 2) identify quantifiable markers of altered cervical spinal cord physiology, 3) quantify reductions in central activation and fatigue 4) evaluate potential genetic variants that may be associated with chronic pain after a MVC and 5) determine the mediational influence of psychosocial factors on recovery rates following whiplash injury, as a potential mechanism underlying the transition to chronic pain.
62 studies on the registry are indexed under Whiplash Injuries; 9 are open to participants now.
This study's enrollment of 97 is above the median of 61 across 44 interventional studies indexed under Whiplash Injuries.
Browse Whiplash Injuries studies →Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
RNA/DNA blood sample will be collected. Participant will complete questionnaires, MRI and strength and reflex testing.
Device: Pedometer · Device: MRI
Number of Participants With Muscle Fat Expression by Magnetic Resonance Imaging (MRI)
A 2-point Dixon examination included the cervical spine (C3 to C7) and the leg. The parameters: Repetition Time (TR) = 6.59 ms, TE 1 = 2.45 ms Echo Time (TE) 2 = 3.675 ms, flip angle = 12°, Bandwidth (BW\_ 1 = 510 BW 2 = 660 Hz/Px and an imaging matrix of 448 x 266. A 12-channel head coil and 4-channel neck coil was used as a receiver. A single slab was placed over the cervical spine with 36 partitions and thickness of 3mm with slab oversampling of 22% to prevent aliasing in the 3D direction. The in-plane resolution was 0.7mm with Field of View (FOV) of 320 x 190mm and 6 averages; Acquisition Time (TA) of 4:23 min. A FOV of 320-340mm was used on the lower extremity muscles using a 16-channel body array surface coil. 60 slices per slab; slice thickness 5mm and a slice oversampling of 6.7%. TA was 4:12 min, 4 averages and in-plane resolution of 0.5 mm. Analysis of the MRI was performed post hoc using customized imaging analysis programs created in MatLab (Version 2014b).
Time frame: < 1 week; 2 weeks; 3 months; 1 year of motor vehicle collision (MVC)
Neck Disability Index (NDI) Questionnaire
This questionnaire will assess the influence of psychosocial factors on neck pain and disability with a range of 0 to 50, with "0" being no disability. The Neck Disability Index (NDI) is a self-reported questionnaire used to measure how neck pain affects a person's daily functioning and quality of life. It is one of the most widely used outcome measures for patients with neck disorders, including chronic neck pain, whiplash, and cervical radiculopathy. The NDI contains 10 sections, each addressing a different aspect of daily life: Each section is scored from: 0 = No disability 5 = Maximum disability The scores from all 10 sections are summed: Raw score range: 0-50 Percentage score: (Raw Score ÷ 50) × 100 Higher scores indicate greater disability due to neck pain. Participants were sorted into three categories based on their score: Recovered (0% to \<8%), Mild (8% to \<30%), and Moderate/severe (≥30%)
Time frame: Baseline
Coping Strategy Questionnaire-C
The Coping Strategy Questionnaire (CSQ-C) is a patient-reported measure used to assess how individuals cope with pain, particularly chronic pain. It evaluates the cognitive and behavioral strategies a person uses when experiencing pain. The CSQ contains 48-50 items organized into eight subscales, each with six items. Respondents rate how often they use each coping strategy when in pain. 0 = Never do that 6 = Always do that Each subscale score ranges from 0 to 36 The CSQ also includes two single-item ratings assessing: * Perceived control over pain * Ability to decrease pain Each is scored from 0 to 6 We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Pain Management Inventory (PMI) Questionnaire
The Pain Management Inventory (PMI) Questionnaire is a patient-reported measure used to assess active and passive coping strategies used by individuals with chronic pain. Each item is rated according to how often the respondent uses the strategy when in pain: 1= never 5= very often The scores are summed within subscales The questionnaire has 18 items divided into: Active Coping (11 items) Score range: 11-55 points Passive Coping (7 items) Score range: 7-35 points Higher scores = greater use of pain management strategies. We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Tampa Questionnaire
The Tampa Questionnaire is a patient-reported questionnaire that measures fear of movement, physical activity, and re-injury in people with pain conditions. Kinesiophobia is defined as an excessive fear that movement will cause pain or another injury. 11 items, Each item scored on a 4-point Likert scale: 1. = Strongly disagree 2. = Disagree 3. = Agree 4. = Strongly agree Total sore 11-44 points, higher scores indicate greater fear of movement. We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Post-traumatic Diagnostic Scale (PDS) Questionnaire
The Posttraumatic Diagnostic Scale (PDS) is a self-report questionnaire used to assess the presence and severity of Post-Traumatic Stress Disorder (PTSD) symptoms related to a specific traumatic event. It measures 20 PTSD symptom items corresponding to DSM-5 criteria Each PTSD symptom item is rated on a 0-4 scale ): 0 (not at all) 1 (once a week or less) 2 (2-3 times a week) 3 (4-5 times a week) 4 (6 or more times a week) Total Score Minimum: 0 Maximum: 80 Higher scores indicate greater PTSD symptom severity. We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Impact of Events Scale Questionnaire
The Impact of Event Scale (IES) is a self-report questionnaire to measure a person's subjective distress following a specific traumatic or stressful life event. The original IES assesses two core trauma-related symptom domains: Intrusion and Avoidance 15 items total 7 Intrusion items 8 Avoidance items For each item respondents rate symptoms experienced during the past 7 days related to a specific event. 0 (Not at all) 1 (Rarely) 3 (Sometimes) 5 (Often) Score Ranges: Intrusion 0-35 Avoidance 0-40 Total 0-75 Higher scores indicate greater trauma-related distress. We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Center for Epidemiological Studies - Depression Scale Questionnaire
The Center for Epidemiologic Studies Depression Scale (CES-D) is a widely used 20-item self-report screening questionnaire designed to measure depressive symptoms experienced during the past week. Each item is scored from 0 to 3. 0 (Rarely) 1 (Some of the time) 2 (Occasionally) 3 (Most of the time) Total Score range: 0-60 Higher scores indicate more depressive symptoms We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Hospital Anxiety and Depression Scale Questionnaire
The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report questionnaire to screen for symptoms of anxiety and depression The HADS contains 14 items divided into two subscales: HADS-A (Anxiety): 7 items HADS-D (Depression): 7 items Each item is scored from 0 to 3 Total Score Ranges: HADS-A: 0-21 HADS-D: 0-21 HADS Total: 0-42 Higher scores indicate greater severity We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
Traumatic Injuries Distress Scale
The Traumatic Injuries Distress Scale (TIDS) is a 12-item self-report questionnaire designed to measure the level of psychological distress experienced after a recent musculoskeletal injury Overall TIDS Score 0-24 Higher scores indicate greater distress and greater risk for delayed recovery We are reporting the number of participants who completed the questionnaire at each time point
Time frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
Prediction of Post-MVC Chronic Axial Pain Assessment
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
Time frame: Baseline visit
Follow-Up Data Collection Form for Clinical Prediction
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
Time frame: 2 week; 3 month; 1 year of MVC
Pedometer: Wear for 2 Consecutive Weeks
The pedometer will record changes in activity level.
Time frame: 2 weeks; 3 months after MVC
RNA and DNA Blood Collection
The samples will evaluate potential genetic variants that may be associated with chronic pain after a MVC.
Time frame: at enrollment, within a week of MVC
Strength and Reflex Testing in the Lower Leg
Lower leg muscle strength is typically graded using the Medical Research Council (MRC) Muscle Strength Scale 0 (No muscle contraction) 1 (Trace Muscle Contraction) 2 (Movement possible with gravity eliminated) 3 (Movement against gravity only) 4 (Movement against some resistance) 5 (Normal strength) Deep tendon reflexes are graded on a 0-4 scale. 0 (absent) 1 (diminished) 2 (normal) 3 (brisk) 4 (very brisk/hyperactive) We are reporting the number of participants who consented to testing.
Time frame: 2 weeks; 3 months; 1 year
| Milestone | Procedures |
|---|---|
| Started | 97 |
| Completed visit 3 (3 months after baseline) | 97 |
| Completed | 78 |
| Not completed | 19 |
| Withdrew: Lost to follow-up | 19 |
A 2-point Dixon examination included the cervical spine (C3 to C7) and the leg. The parameters: Repetition Time (TR) = 6.59 ms, TE 1 = 2.45 ms Echo Time (TE) 2 = 3.675 ms, flip angle = 12°, Bandwidth (BW\_ 1 = 510 BW 2 = 660 Hz/Px and an imaging matrix of 448 x 266. A 12-channel head coil and 4-channel neck coil was used as a receiver. A single slab was placed over the cervical spine with 36 partitions and thickness of 3mm with slab oversampling of 22% to prevent aliasing in the 3D direction. The in-plane resolution was 0.7mm with Field of View (FOV) of 320 x 190mm and 6 averages; Acquisition Time (TA) of 4:23 min. A FOV of 320-340mm was used on the lower extremity muscles using a 16-channel body array surface coil. 60 slices per slab; slice thickness 5mm and a slice oversampling of 6.7%. TA was 4:12 min, 4 averages and in-plane resolution of 0.5 mm. Analysis of the MRI was performed post hoc using customized imaging analysis programs created in MatLab (Version 2014b).
| Participants | Procedures |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
This questionnaire will assess the influence of psychosocial factors on neck pain and disability with a range of 0 to 50, with "0" being no disability. The Neck Disability Index (NDI) is a self-reported questionnaire used to measure how neck pain affects a person's daily functioning and quality of life. It is one of the most widely used outcome measures for patients with neck disorders, including chronic neck pain, whiplash, and cervical radiculopathy. The NDI contains 10 sections, each addressing a different aspect of daily life: Each section is scored from: 0 = No disability 5 = Maximum disability The scores from all 10 sections are summed: Raw score range: 0-50 Percentage score: (Raw Score ÷ 50) × 100 Higher scores indicate greater disability due to neck pain. Participants were sorted into three categories based on their score: Recovered (0% to \<8%), Mild (8% to \<30%), and Moderate/severe (≥30%)
| Participants | Neck Disability Index Questionnaire |
|---|---|
| Recovered | 37 |
| Mild | 44 |
| Moderate/Severe | 16 |
The Coping Strategy Questionnaire (CSQ-C) is a patient-reported measure used to assess how individuals cope with pain, particularly chronic pain. It evaluates the cognitive and behavioral strategies a person uses when experiencing pain. The CSQ contains 48-50 items organized into eight subscales, each with six items. Respondents rate how often they use each coping strategy when in pain. 0 = Never do that 6 = Always do that Each subscale score ranges from 0 to 36 The CSQ also includes two single-item ratings assessing: * Perceived control over pain * Ability to decrease pain Each is scored from 0 to 6 We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Pain Management Inventory (PMI) Questionnaire is a patient-reported measure used to assess active and passive coping strategies used by individuals with chronic pain. Each item is rated according to how often the respondent uses the strategy when in pain: 1= never 5= very often The scores are summed within subscales The questionnaire has 18 items divided into: Active Coping (11 items) Score range: 11-55 points Passive Coping (7 items) Score range: 7-35 points Higher scores = greater use of pain management strategies. We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Tampa Questionnaire is a patient-reported questionnaire that measures fear of movement, physical activity, and re-injury in people with pain conditions. Kinesiophobia is defined as an excessive fear that movement will cause pain or another injury. 11 items, Each item scored on a 4-point Likert scale: 1. = Strongly disagree 2. = Disagree 3. = Agree 4. = Strongly agree Total sore 11-44 points, higher scores indicate greater fear of movement. We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Posttraumatic Diagnostic Scale (PDS) is a self-report questionnaire used to assess the presence and severity of Post-Traumatic Stress Disorder (PTSD) symptoms related to a specific traumatic event. It measures 20 PTSD symptom items corresponding to DSM-5 criteria Each PTSD symptom item is rated on a 0-4 scale ): 0 (not at all) 1 (once a week or less) 2 (2-3 times a week) 3 (4-5 times a week) 4 (6 or more times a week) Total Score Minimum: 0 Maximum: 80 Higher scores indicate greater PTSD symptom severity. We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Impact of Event Scale (IES) is a self-report questionnaire to measure a person's subjective distress following a specific traumatic or stressful life event. The original IES assesses two core trauma-related symptom domains: Intrusion and Avoidance 15 items total 7 Intrusion items 8 Avoidance items For each item respondents rate symptoms experienced during the past 7 days related to a specific event. 0 (Not at all) 1 (Rarely) 3 (Sometimes) 5 (Often) Score Ranges: Intrusion 0-35 Avoidance 0-40 Total 0-75 Higher scores indicate greater trauma-related distress. We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Center for Epidemiologic Studies Depression Scale (CES-D) is a widely used 20-item self-report screening questionnaire designed to measure depressive symptoms experienced during the past week. Each item is scored from 0 to 3. 0 (Rarely) 1 (Some of the time) 2 (Occasionally) 3 (Most of the time) Total Score range: 0-60 Higher scores indicate more depressive symptoms We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Center for Epidemiological Studies - Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report questionnaire to screen for symptoms of anxiety and depression The HADS contains 14 items divided into two subscales: HADS-A (Anxiety): 7 items HADS-D (Depression): 7 items Each item is scored from 0 to 3 Total Score Ranges: HADS-A: 0-21 HADS-D: 0-21 HADS Total: 0-42 Higher scores indicate greater severity We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Hospital Anxiety and Depression Scale Questionnaire |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
The Traumatic Injuries Distress Scale (TIDS) is a 12-item self-report questionnaire designed to measure the level of psychological distress experienced after a recent musculoskeletal injury Overall TIDS Score 0-24 Higher scores indicate greater distress and greater risk for delayed recovery We are reporting the number of participants who completed the questionnaire at each time point
| Participants | Traumatic Injuries Distress Scale |
|---|---|
| < 1 week | 97 |
| 2 weeks | 97 |
| 3 months | 97 |
| 12 months | 78 |
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
No measurements were reported for this outcome.
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
No measurements were reported for this outcome.
The pedometer will record changes in activity level.
No measurements were reported for this outcome.
The samples will evaluate potential genetic variants that may be associated with chronic pain after a MVC.
| Participants | RNA and DNA Blood Collection |
|---|---|
| Consented for Blood Draw | 43 |
| Did not Consent for Blood Draw | 54 |
Lower leg muscle strength is typically graded using the Medical Research Council (MRC) Muscle Strength Scale 0 (No muscle contraction) 1 (Trace Muscle Contraction) 2 (Movement possible with gravity eliminated) 3 (Movement against gravity only) 4 (Movement against some resistance) 5 (Normal strength) Deep tendon reflexes are graded on a 0-4 scale. 0 (absent) 1 (diminished) 2 (normal) 3 (brisk) 4 (very brisk/hyperactive) We are reporting the number of participants who consented to testing.
| Participants | Strength and Reflex Testing in the Lower Leg |
|---|---|
| 2 weeks | 95 |
| 3 months | 92 |
| 12 months | 73 |
Collected over 3 months for 97 participants 12 months for 78 participants. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Procedures | 0/97 (0%) | 0/97 (0%) | 0/97 (0%) |
19 participants completed the baseline visit but withdrew or were excluded later. Hence, the number of participants who completed the study is lower in the Participant Flow module than the number of participants in the baseline population.
| Age, Categorical(Participants) | Procedures |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 97 |
| >=65 years | 0 |
| Age, Continuous(years) | Procedures |
|---|---|
| Mean | 34.69 ± 11.08 |
| Sex: Female, Male(Participants) | Procedures |
|---|---|
| Female | 72 |
| Male | 25 |
| Ethnicity (NIH/OMB)(Participants) | Procedures |
|---|---|
| Hispanic or Latino | 9 |
| Not Hispanic or Latino | 85 |
| Unknown or Not Reported | 3 |
| Region of Enrollment(Participants) | Procedures |
|---|---|
| United States | 97 |
| Race (NIH/OMB)(Participants) | Procedures |
|---|---|
| American Indian/ Alaska Native | 0 |
| Asian | 7 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 35 |
| White | 43 |
| More than One Race | 0 |
| Unknown or Not Reported | 12 |
PDFs hosted by the registry, ClinicalTrials.gov.
The record gives a start of Jul 2014, a primary completion of May 2020 and a completion of May 2020. It does not say whether these dates are actual or estimated.
Results were first posted in Oct 2026, 6 years 5 months after primary completion.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.